Diabetes Medication Market: Costs and Utilization of Glucagon-Like Peptide 1 (GLP-1) Prescriptions From 2008 to 2023

The figure shows the market share of prescriptions filled from 2008 to 2023. Over this period, the GLP-1 prescription market shifted from predominantly Byetta to a broader distribution across Victoza, Trulicity, and Ozempic, with smaller shares of Rybelsus and Mounjaro by 2023.